Skip to main content
Log in

Resolvin D1 attenuates depressive-like behavior in LPS-challenged mice by promoting microglial autophagy

  • Original Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

It has been proven that neuroinflammation triggered by microglial activation is the pathogenesis of depression associated with sepsis. An endogenous lipid mediator known as resolvin D1 (RvD1) is known to have anti-inflammatory effects in a sepsis model. However, it remains unknown if the effects of RvD1 on inflammatory responses are regulated by microglial autophagy. The current study investigated the role of RvD1-induced microglial autophagy in neuroinflammation. The findings showed that RvD1 reverses LPS-induced autophagy inhibition in microglia. RvD1 treatment significantly inhibits inflammatory responses by preventing NF-κB nuclear translocation and microglial M1 phenotypic transition. RvD1 exhibits an attenuation of neurotoxicity in both in vivo and in vitro models of sepsis. Following RvD1 injection, depressive-like behaviors in SAE mice were significantly improved. Notably, the aforesaid effects of RvD1 were eliminated by 3-MA, demonstrating that microglial autophagy was modulated. In conclusion, our findings shed new light on the involvement of microglial autophagy in SAE and emphasize the potential benefits of RvD1 as a promising therapeutic agent in the treatment of depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

All the raw data of this study are available from the corresponding author, Zhongliang Dai, upon reasonable request.

Abbreviations

BECN1:

Beclin1

Casp.3:

Cleaved-caspase3

C-PARP:

Cleaved poly ADP-ribose polymerase

FST:

Forced swim test

LPS:

Lipopolysaccharides

NF-κB:

Nuclear factor-kappa-B

OFT:

Open field test

RvD1:

Resolvin D1

SAE:

Sepsis-associated encephalopathy

TST:

Tail suspension test

TEM:

Transmission electron microscopy

References

Download references

Funding

This study was supported by the grants from the National Natural Science Foundation of China (81902016), the Natural Science Foundation of Guangdong (2022A1515012129) and the Shenzhen Municipal Science and Technology Foundation (JCYJ20220530152615035).

Author information

Authors and Affiliations

Authors

Contributions

WX: Investigation, visualization, writing-original draft preparation. HW: Investigation. HZ: Investigation. YX: Methodology. WG: Investigation. LC: Software. LC: Data Curation. ZD: Writing-reviewing and editing, conceptualization, supervision.

Corresponding author

Correspondence to Zhongliang Dai.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethics approval

All experiments procedures involving animals were granted permission by the committee of experimental animals of Tongji Medical College in Huazhong University of Science and Technology (Director: Shunchang Zhou; Date: Mar 5th, 2019; Certificate number: 2019-S1547).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiong, W., Wang, H., Zhang, H. et al. Resolvin D1 attenuates depressive-like behavior in LPS-challenged mice by promoting microglial autophagy. Inflammopharmacol 31, 2061–2075 (2023). https://doi.org/10.1007/s10787-023-01234-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-023-01234-9

Keywords

Navigation